IPO registrations (S-1, F-1) · Registrants
Caribou Biosciences, Inc.
- SEC CIK
- 1619856 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2021-07-01, last 2021-07-22; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2021-07-23; declared effective 2021-07-22
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 2929 7TH STREET, SUITE 105, Berkeley, CA 94710
- EIN
- 45-3728228
- Ticker
- CRBU (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Caribou Biosciences, Inc. on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2021-07-22)
- Final price
- $3.33 per share, below the range (424B4 filed 2021-07-23, an initial public offering)
- Shares sold
- 19,000,000
- Gross proceeds
- $63,270,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CRBU
- Lead underwriters
- BofA Securities; Citigroup (6,365,000 shares); Leerink Partners (5,700,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: CARIBOU BIOSCIENCES, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Caribou Biosciences, Inc. Fuzzy (name and state)
- Business registration: Caribou Biosciences, Inc. Fuzzy (name and state)
- Business registration: CARIBOU BIOSCIENCES, INC. Fuzzy (name and state)
- Business registration: CARIBOU BIOSCIENCES, INC. Fuzzy (name and state)
- Business registration: CARIBOU BIOSCIENCES, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: CARIBOU BIOSCIENCES, INC. EXACT (EIN (EXACT))
- Federal award recipient: CARIBOU BIOSCIENCES, INC Fuzzy (name and state)
- Form D issuer: Caribou Biosciences, Inc. EXACT (CIK (EXACT))
- SEC filer: Caribou Biosciences, Inc. EXACT (CIK (EXACT))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-07-01 | S-1 | S-1 (registration) | Caribou Biosciences, Inc. | 0001193125-21-206262 ↗ |
| 2021-07-19 | S-1/A | S-1/A (amendment) | Caribou Biosciences, Inc. | 0001193125-21-217974 ↗ |
| 2021-07-22 | S-1/A | S-1/A (amendment) | Caribou Biosciences, Inc. | 0001193125-21-221318 ↗ |
| 2021-07-22 | S-1MEF | S-1MEF (added securities) | Caribou Biosciences, Inc. | 0001193125-21-222147 ↗ |
| 2021-07-22 | EFFECT | EFFECT (declared effective) | Caribou Biosciences, Inc. | 9999999995-21-002886 ↗ |
| 2021-07-23 | 424B4 | 424B4 (final prospectus) | Caribou Biosciences, Inc. | 0001193125-21-223038 ↗ |
| 2022-08-16 | EFFECT | EFFECT (declared effective) | Caribou Biosciences, Inc. | 9999999995-22-002403 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-22 | S-1/A | registration statement | $14.00–$16.00 | 17,000,000 | - | Nasdaq CRBU | 3 | primary document; range, shares headline, cover names 3 | document ↗ | |
| 2021-07-23 | 424B4 | final prospectus | $3.33 | 19,000,000 | $63,270,000 | Nasdaq CRBU | 3 | primary document; price line, shares headline, proceeds computed, underwriting table 2, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Braunstein Scott | Director | 6 | 2021–2026 | ||
| FMR LLC | Other; TenPercentOwnerOther | 2 | 2021 | ||
| GUGGENHIME ANDREW | Director | 6 | 2021–2026 | ||
| Haurwitz Rachel E. | Director,Officer | President and CEO; See Remarks | 13 | 2021–2026 | |
| Kanner Steven | Officer | Chief Scientific Officer; See Remarks | 11 | 2021–2025 | |
| Long-McGie Jeffrey Stephen | Director | 1 | 2021 | ||
| MCCLUNG BARBARA G | Officer | Chief Legal Officer; See Remarks | 9 | 2021–2026 | |
| O'Byrne Jason | Officer | Chief Financial Officer; See Remarks | 5 | 2021–2024 | |
| Sacks Natalie | Director | 6 | 2021–2026 | ||
| Fischesser Ryan | Officer | See Remarks; VP of Finance and Controller | 10 | 2021–2024 | |
| Whiting Nancy | Director | 8 | 2021–2026 | ||
| Zheng Ran | Director | 7 | 2021–2026 | ||
| Khan Ruhi Ahmad | Officer | Chief Business Officer | 7 | 2021–2026 | |
| Richardson-Heron Dara | Director | 6 | 2021–2026 | ||
| Rizvi Syed Ali-aamir | Officer | Chief Medical Officer | 4 | 2022–2023 | |
| JOHNSON DAVID LEE | Director | 6 | 2022–2026 | ||
| Kelly Timothy P | Officer | Chief Technology Officer | 6 | 2024–2026 | |
| Albertson Tina M. | Officer | Chief Medical Officer | 4 | 2024–2026 | |
| Ryali Sriram | Officer | Chief Financial Officer | 4 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2021-03-05 | Caribou Biosciences, Inc. | Biotechnology | $114,999,613 | $114,999,613 | 36 | 1 |
| 2016-05-25 | Caribou Biosciences, Inc. | Biotechnology | $30,070,244 | $14,459,306 | 11 | 1 |
| 2014-09-23 | Caribou Biosciences, Inc. | Biotechnology | $11,549,904 | $11,549,904 | 14 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Caribou Biosciences, Inc. | CA | State business registries | name and state |
| Business registration | Caribou Biosciences, Inc. | CA | State business registries | name and state |
| Business registration | CARIBOU BIOSCIENCES, INC. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | CARIBOU BIOSCIENCES, INC. | CA | State business registries | name and state |
| Business registration | CARIBOU BIOSCIENCES, INC. | CA | State business registries | name and state |
| Business registration | CARIBOU BIOSCIENCES, INC. | CA | State business registries | name and state |
| Federal award recipient | CARIBOU BIOSCIENCES, INC | CA | Federal spending (USAspending) | name and state |
| Form D issuer | Caribou Biosciences, Inc. | CA | Form D private offerings | CIK (EXACT) |
| Patent assignee | Caribou Biosciences, Inc. | CA | Patents (USPTO) | name and state |
| SEC filer | Caribou Biosciences, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Caribou Biosciences, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | CARIBOU BIOSCIENCES, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.